Huntington's Disease Clinical Trials Corner: April 2022

Area of Science:

• Neurodegenerative Diseases
• Clinical Research
• Genetics

Background:

• Huntington's disease (HD) is a fatal, autosomal dominant neurodegenerative disorder.
• There is a critical need for effective therapeutic interventions for HD.
• Clinical trials are essential for advancing HD treatment strategies.

Purpose of the Study:

• To provide an update on significant ongoing clinical trials for Huntington's disease.
• To detail specific trials such as GENERATION HD1, PRECISION-HD1/2, SELECT-HD, and VIBRANT-HD.
• To offer a consolidated resource of all registered and active HD clinical trials.

Main Methods:

• Review of current literature and clinical trial databases.
• Summarization of key trial designs and objectives.
• Compilation of data on registered and ongoing Huntington's disease studies.

Main Results:

• Expansion on the GENERATION HD1, PRECISION-HD1/2, SELECT-HD, and VIBRANT-HD trials.
• Identification of multiple other registered and ongoing clinical trials for HD.
• Overview of the current landscape of therapeutic development in HD.

Conclusions:

• The field of Huntington's disease research is active with numerous ongoing clinical trials.
• These trials represent diverse therapeutic approaches targeting HD.
• This compilation serves as a valuable resource for researchers, clinicians, and patients interested in HD clinical research.